Product logins

Find logins to all Clarivate products below.


Blog: Clinical trials

Here you will find relevant articles and insight into all Clarivate related products and news.

Europe looks to shore up global competitiveness with the E.U. Biotech Act Europe looks to shore up global competitiveness with the E.U. Biotech Act
Blog June 22, 2026
Europe looks to shore up global competitiveness with the E.U. Biotech Act
Biopharma Biotech Business Development
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Blog June 9, 2026
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Bispecific antibodies BsAb Clinical trials
The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Biopharma Biotech Clinical trials
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Blog February 24, 2026
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Biopharma Biotech Clinical trials

Clinical trials

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Europe looks to shore up global competitiveness with the E.U. Biotech Act Europe looks to shore up global competitiveness with the E.U. Biotech Act
Blog June 22, 2026
Europe looks to shore up global competitiveness with the E.U. Biotech Act
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Blog June 9, 2026
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Tolebrutinib: when safety concerns override efficacy signals Tolebrutinib: when safety concerns override efficacy signals
Blog February 24, 2026
Tolebrutinib: when safety concerns override efficacy signals
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Blog February 24, 2026
Navigating Complete Response Letters: how Clarivate solutions can help pharmas chart their path to approval
Machine curation in action: a new approach to essential tremor epidemiology Machine curation in action: a new approach to essential tremor epidemiology
Blog November 17, 2025
Machine curation in action: a new approach to essential tremor epidemiology
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium
Blog July 8, 2024
Perceptions of pharmaceutical industry affiliates on the New Active Substance Work-Sharing Initiative of the Access Consortium